Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Gilles, Zambardi"'
Autor:
Maxime Paluch, Manon Lleres-Vadeboin, Hélène Poupet, Emmanuel Chanard, Nathalie Wilhelm, Safia Nadji, Laurence Prots, Yohann Bala, Gilles Zambardi, Christian Cattoen
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 106:115950
Autor:
Michael Kresken, Gilles Zambardi, Christopher L. Emery, Marion Pompilio, Alex van Belkum, Yun X Ying, Diane Halimi, Dominique Dechaume, Tom Armstrong, Laurine S Blanchard
Publikováno v:
Journal of Clinical Microbiology. 60
Plazomicin (PLZ), brand name ZEMDRI (Cipla Therapeutics), is a novel aminoglycoside antibiotic approved by the US Food and Drug Administration (FDA) for treatment of complicated urinary tract infections including pyelonephritis. ETEST® is a gradient
Autor:
Alex van Belkum, Leah B. Soriaga, Matthew C. LaFave, Srividya Akella, Jean-Baptiste Veyrieras, E. Magda Barbu, Dee Shortridge, Bernadette Blanc, Gregory Hannum, Gilles Zambardi, Kristofer Miller, Mark C. Enright, Nathalie Mugnier, Daniel Brami, Stéphane Schicklin, Martina Felderman, Ariel S. Schwartz, Toby H. Richardson, Todd C. Peterson, Bolyn Hubby, Kyle C. Cady
Publikováno v:
mBio, Vol 6, Iss 6 (2015)
ABSTRACT Pseudomonas aeruginosa is an antibiotic-refractory pathogen with a large genome and extensive genotypic diversity. Historically, P. aeruginosa has been a major model system for understanding the molecular mechanisms underlying type I cluster
Externí odkaz:
https://doaj.org/article/f38c9e5c88214fcc8f66550e1d9cd651
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 40:1333-1335
Time to reporting antimicrobial susceptibility testing (AST) results to physicians plays an essential role in antibiotic stewardship programs. Expert software has been developed for facilitating the microbiologists’ AST review process. The reliabil
Autor:
Meghan A. Wallace, Carey-Ann D. Burnham, Sergio García-Fernández, María García-Castillo, Rafael Cantón, Tom Armstrong, Gilles Zambardi, Yohann Bala, Dwight J. Hardy
Publikováno v:
Journal of Clinical Microbiology. 58
Piperacillin-tazobactam (P/T) is a β-lactam-β-lactamase inhibitor combination frequently used in the hospital setting. Etest is a gradient diffusion method that represents an alternative to broth microdilution (BMD) for performing antimicrobial sus
Autor:
Elizabeth Pinet, Valérie Collin, Christine Franceschi, Jean-Marie Pagès, Gilles Zambardi, Anne Davin-Regli
Publikováno v:
Journal of medical microbiology. 69(1)
Introduction. The worldwide emergence of carbapenem resistance in Gram-negative bacteria makes the development of simple tests mandatory to identify antimicrobial resistance mechanisms. Enzymatic and membrane barriers are the prominent resistance mec
Autor:
Veronique Sauvonnet, Elodie Escoffier, Christine Franceschi, Diane Halimi, Roland Martelin, Laetitia Pellet, Gilles Zambardi
Publikováno v:
Open Forum Infectious Diseases
Background Species belonging to the Acinetobacter baumannii-calcoaceticus (ABC) complex, such as A. baumannii, A. pittii and A. nosocomialis, are a major cause of hospital acquired infections and outbreaks with increasing occurrence of multidrug-resi
Correlation between phenotypic antibiotic susceptibility and the resistome in Pseudomonas aeruginosa
Autor:
E. Magda Barbu, Magali Jaillard, Kyle C. Cady, Mark C. Enright, Nathalie Mugnier, Dee Shortridge, Jean-Baptiste Veyrieras, Ghislaine Guigon, David Creely, W. Michael Dunne, Stéphane Schicklin, Alex van Belkum, Gilles Zambardi, Christophe Le Priol, Bernadette Blanc
Publikováno v:
International Journal of Antimicrobial Agents. 50:210-218
Genetic determinants of antibiotic resistance (AR) have been extensively investigated. High-throughput sequencing allows for the assessment of the relationship between genotype and phenotype. A panel of 672 Pseudomonas aeruginosa strains was analysed
Autor:
Sergio, García-Fernández, Yohann, Bala, Tom, Armstrong, María, García-Castillo, C A, Burnham, Meghan A, Wallace, Dwight, Hardy, Gilles, Zambardi, Rafael, Cantón
Publikováno v:
J Clin Microbiol
In this issue of the Journal of Clinical Microbiology, S. García-Fernandez, Y. Bala, T. Armstrong, M. Garcia-Castillo, et al. (J Clin Microbiol 58:e01042-19, 2020, https://doi.org/10.1128/JCM.01042-19) describe the performance of a reformulated Etes
Publikováno v:
International journal of antimicrobial agents. 53(5)
Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) do not completely predict the bactericidal nature of the antimicrobial agent. Patients with pathogens having MICs near the clinical breakpoint experience a higher ris